347 related articles for article (PubMed ID: 7504839)
1. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Galili U
Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
[TBL] [Abstract][Full Text] [Related]
2. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells.
Thall A; Etienne-Decerf J; Winand RJ; Galili U
Autoimmunity; 1991; 10(2):81-7. PubMed ID: 1723633
[TBL] [Abstract][Full Text] [Related]
3. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
Galili U; Shohet SB; Kobrin E; Stults CL; Macher BA
J Biol Chem; 1988 Nov; 263(33):17755-62. PubMed ID: 2460463
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.
Galili U; Clark MR; Shohet SB; Buehler J; Macher BA
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1369-73. PubMed ID: 2434954
[TBL] [Abstract][Full Text] [Related]
5. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
6. Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.
Hamadeh RM; Galili U; Zhou P; Griffiss JM
Clin Diagn Lab Immunol; 1995 Mar; 2(2):125-31. PubMed ID: 7697518
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes?
Galili U
Lancet; 1989 Aug; 2(8659):358-61. PubMed ID: 2474731
[TBL] [Abstract][Full Text] [Related]
8. Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
Repik PM; Strizki JM; Galili U
J Gen Virol; 1994 May; 75 ( Pt 5)():1177-81. PubMed ID: 7513744
[TBL] [Abstract][Full Text] [Related]
9. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
10. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
Galili U
J Mol Evol; 2015 Jan; 80(1):1-9. PubMed ID: 25315716
[TBL] [Abstract][Full Text] [Related]
11. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
12. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.
Galili U; Swanson K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7401-4. PubMed ID: 1908095
[TBL] [Abstract][Full Text] [Related]
13. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
14. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
15. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.
Galili U; Tibell A; Samuelsson B; Rydberg L; Groth CG
Transplantation; 1995 Jun; 59(11):1549-56. PubMed ID: 7539957
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
LaTemple DC; Henion TR; Anaraki F; Galili U
Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.
Galili U; Repik PM; Anaraki F; Mozdzanowska K; Washko G; Gerhard W
Vaccine; 1996 Mar; 14(4):321-8. PubMed ID: 8744560
[TBL] [Abstract][Full Text] [Related]
18. Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations.
Wang L; Radic MZ; Galili U
J Immunol; 1995 Aug; 155(3):1276-85. PubMed ID: 7543518
[TBL] [Abstract][Full Text] [Related]
19. A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis.
Gollogly L; Castronovo V
Neoplasma; 1996; 43(5):285-9. PubMed ID: 8996545
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
Rother RP; Fodor WL; Springhorn JP; Birks CW; Setter E; Sandrin MS; Squinto SP; Rollins SA
J Exp Med; 1995 Nov; 182(5):1345-55. PubMed ID: 7595205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
